1. Lv, Lei, Zhao, Yujia, Wei, Qinqin, Zhao, Ye, Yi, Qiyi. 2020. Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. In Cancer cell international, 20, 210. doi:10.1186/s12935-020-01298-5. https://pubmed.ncbi.nlm.nih.gov/32514254/
2. Wu, Min, Jiang, Li. 2021. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma. In Digestive diseases and sciences, 67, 146-158. doi:10.1007/s10620-021-06832-7. https://pubmed.ncbi.nlm.nih.gov/33495920/
3. Ke, Lu, Che, Ye-Na, Cao, Yun-xia, Yi, Long, Wang, Yong. 2010. Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome. In Journal of women's health (2002), 19, 2227-32. doi:10.1089/jwh.2009.1902. https://pubmed.ncbi.nlm.nih.gov/21039282/
4. Jones, Michelle R, Italiano, Lisa, Wilson, Scott G, Watts, Gerald F, Stuckey, Bronwyn G A. . Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. In Fertility and sterility, 86, 1438-46. doi:. https://pubmed.ncbi.nlm.nih.gov/17070195/
5. Ju, Rong, Wu, Wei, Fei, Juan, Wu, Jie, Wang, Xinru. 2014. Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population. In European journal of endocrinology, 172, 227-33. doi:10.1530/EJE-14-0615. https://pubmed.ncbi.nlm.nih.gov/25422294/
智鼠故事 
